FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies

نویسندگان

  • Laurian Zuidmeer-Jongejan
  • Montserrat Fernandez-Rivas
  • Lars K Poulsen
  • Angela Neubauer
  • Juan Asturias
  • Lars Blom
  • Joyce Boye
  • Carsten Bindslev-Jensen
  • Michael Clausen
  • Rosa Ferrara
  • Paula Garosi
  • Hans Huber
  • Bettina M Jensen
  • Stef Koppelman
  • Marek L Kowalski
  • Anna Lewandowska-Polak
  • Birgit Linhart
  • Bernard Maillere
  • Adriano Mari
  • Alberto Martinez
  • Clare EN Mills
  • Claudio Nicoletti
  • Dirk-Jan Opstelten
  • Nikos G Papadopoulos
  • Antonio Portoles
  • Neil Rigby
  • Enrico Scala
  • Heidi J Schnoor
  • Sigurveig T Sigurdardottir
  • George Stavroulakis
  • Frank Stolz
  • Ines Swoboda
  • Rudolf Valenta
  • Rob van den Hout
  • Serge A Versteeg
  • Marianne Witten
  • Ronald van Ree
چکیده

The FAST project (Food Allergy Specific Immunotherapy) aims at the development of safe and effective treatment of food allergies, targeting prevalent, persistent and severe allergy to fish and peach. Classical allergen-specific immunotherapy (SIT), using subcutaneous injections with aqueous food extracts may be effective but has proven to be accompanied by too many anaphylactic side-effects. FAST aims to develop a safe alternative by replacing food extracts with hypoallergenic recombinant major allergens as the active ingredients of SIT. Both severe fish and peach allergy are caused by a single major allergen, parvalbumin (Cyp c 1) and lipid transfer protein (Pru p 3), respectively. Two approaches are being evaluated for achieving hypoallergenicity, i.e. site-directed mutagenesis and chemical modification. The most promising hypoallergens will be produced under GMP conditions. After pre-clinical testing (toxicology testing and efficacy in mouse models), SCIT with alum-absorbed hypoallergens will be evaluated in phase I/IIa and IIb randomized double-blind placebo-controlled (DBPC) clinical trials, with the DBPC food challenge as primary read-out. To understand the underlying immune mechanisms in depth serological and cellular immune analyses will be performed, allowing identification of novel biomarkers for monitoring treatment efficacy. FAST aims at improving the quality of life of food allergic patients by providing a safe and effective treatment that will significantly lower their threshold for fish or peach intake, thereby decreasing their anxiety and dependence on rescue medication.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The choice of hypoallergens for fish and peach to develop food allergy specific immunotherapy (the FAST project)

Background Classical allergen-specific immunotherapy (SIT), using subcutaneous injections with food extracts, may be effective but dangerous due to anaphylactic side-effects. The FAST project (Food Allergy Specific Immunotherapy) aims at the development of safe and effective treatment of food allergies, targeting persistent and severe allergy to fish (cod) and fruit (peach). Both are caused by ...

متن کامل

Blinding of freeze-dried cod – a recipe developed for the FAST project

Background The FAST project (Food Allergy Specific ImmunoTherapy) aims at the development of safe and effective treatment of food allergies. Classical allergen-specific immunotherapy (SIT) for treatment of food allergy using subcutaneous injections with food extracts has proven to be effective but too dangerous due to anaphylactic side-effects. FAST aims at developing a safe alternative by repl...

متن کامل

Management of Food Allergy

Although food allergy is a major public health problem, currently there is no effective and safe treatment except to avoid the foods .But the need for new options is critical now as the number of children diagnosed with food allergies rises. Avoiding the offending allergen in the diet is the primary treatment of food allergy. Once a food to which the patient is sensitive has been identified, th...

متن کامل

Advances in the Treatment of Food Allergy: Sublingual and Epicutaneous Immunotherapy.

Food allergies continue to increase in prevalence. Standard care is a strict elimination diet, but life-threatening reactions still occur. Allergen immunotherapy has the most potential in treating food allergy. Subcutaneous immunotherapy has not been adopted into food allergy therapy. Oral immunotherapy has a high rate of adverse reactions. Sublingual immunotherapy (SLIT) uses the tolerogenic e...

متن کامل

Immunotherapy in food allergy: towards new strategies.

Allergen avoidance is the standard treatment for managing food allergies. Complete avoidance is difficult, and accidental exposure often occurs. Immunotherapy is a significant focus for treating food allergies, and oral immunotherapy (OIT) appears to be particularly effective in inducing desensitization. The majority of patients who receive OIT show increased threshold doses of their food aller...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 2  شماره 

صفحات  -

تاریخ انتشار 2012